Identification of ADAM12 as a Novel Basigin Sheddase
Open Access
- 22 April 2019
- journal article
- research article
- Published by MDPI AG in International Journal of Molecular Sciences
- Vol. 20 (8) , 1957
Abstract
The transmembrane glycoprotein basigin, a member of the immunoglobulin superfamily, stimulates matrix metalloproteinase (MMP)-mediated extracellular matrix (ECM) degradation and thereby drives cancer cell invasion. Basigin is proteolytically shed from the cell surface and high concentrations of soluble basigin in the blood dictates poor prognosis in cancer patients. A positive correlation between basigin and a disintegrin and metalloproteinase (ADAM)-12 in serum from prostate cancer patients has been reported. Yet, the functional relevance of this correlation is unknown. Here, we show that ADAM12 interacts with basigin and cleaves it in the juxtamembrane region. Specifically, overexpression of ADAM12 increases ectodomain shedding of an alkaline phosphatase-tagged basigin reporter protein from the cell surface. Moreover, CRISPR/Cas9-mediated knockout of ADAM12 in human HeLa carcinoma cells results in reduced shedding of the basigin reporter, which can be rescued by ADAM12 re-expression. We detected endogenous basigin fragments, corresponding to the expected size of the ADAM12-generated ectodomain, in conditioned media from ADAM12 expressing cancer cell-lines, as well as serum samples from a healthy pregnant donor and five bladder cancer patients, known to contain high ADAM12 levels. Supporting the cancer relevance of our findings, we identified several cancer-associated mutations in the basigin membrane proximal region. Subsequent in vitro expression showed that some of these mutants are more prone to ADAM12-mediated shedding and that the shed ectodomain can enhance gelatin degradation by cancer cells. In conclusion, we identified ADAM12 as a novel basigin sheddase with a potential implication in cancer.Keywords
Funding Information
- Kræftens Bekæmpelse (R146-A9211-16-S2)
This publication has 44 references indexed in Scilit:
- ADAM12 is expressed in the tumour vasculature and mediates ectodomain shedding of several membrane-anchored endothelial proteinsBiochemical Journal, 2013
- Cell‐surface Metalloprotease ADAM12 is Internalized by a Clathrin‐ and Grb2‐dependent MechanismTraffic, 2012
- ADAM12 Produced by Tumor Cells Rather than Stromal Cells Accelerates Breast Tumor ProgressionMolecular Cancer Research, 2011
- Complex patterns of ADAM12 mRNA and protein splice variants in the human placentaAnnals of Anatomy - Anatomischer Anzeiger, 2011
- Extracellular engagement of ADAM12 induces clusters of invadopodia with localized ectodomain shedding activityExperimental Cell Research, 2011
- The ADAMs: signalling scissors in the tumour microenvironmentNature Reviews Cancer, 2008
- Basigin-2 Is a Cell Surface Receptor for Soluble Basigin LigandJournal of Biological Chemistry, 2008
- Substrate Selectivity of Epidermal Growth Factor-Receptor Ligand Sheddases and their Regulation by Phorbol Esters and Calcium InfluxMolecular Biology of the Cell, 2007
- A Role for ADAM12 in Breast Tumor Progression and Stromal Cell ApoptosisCancer Research, 2005
- Breast cancer cell-derived EMMPRIN stimulates fibroblast MMP2 release through a phospholipase A2 and 5-lipoxygenase catalyzed pathwayOncogene, 2002